Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07782957 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Study to Assess the Efficacy and Safety of GSK5784283 (Felcorekibart) Compared With Placebo in Participants With Chronic Rhinosinusitis With Nasal Polyps (CRSwNP)

Name: A Study to Assess the Efficacy and Safety of GSK5784283 (Felcorekibart) Compared With Placebo in Participants With Chronic Rhinosinusitis With Nasal Polyps (CRSwNP) — clinical trial record (NCT07782957)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: PERSISTCRSwNP2

StatusNot Yet Recruiting

PhasePhase 3

SponsorGlaxoSmithKline

Started2026-08-31

View on ClinicalTrials.gov ↗

The aim of this study is to assess the efficacy and safety of GSK5784283 administered as add-on maintenance therapy to participants with CRSwNP.

Trial Details

NCT Number	NCT07782957
Lead Sponsor	GlaxoSmithKline
Conditions	Nasal Polyps
Enrollment	218 participants
Start Date	2026-08-31
Primary Completion	2029-03-06 (estimated)
Study Completion	2029-10-30 (estimated)
Updated on ClinicalTrials.gov	2026-08-24